Inventor · disambiguated record
Martin D. Eastgate
Also filed as: EASTGATE MARTIN D
17 granted patents·8 pending applications·15 citations·filing 2013–2023
89Inventor score
Top patents by PatentIndex Score
25 records- 0189US8889869B2Methods for the preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 18, 2014·5 cites·8 claims
- 0286US9249168B2Methods for the preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 2, 2016·3 cites·2 claims
- 0379US9255113B2Methods for the Preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 9, 2016·1 cites·3 claims
- 0478US11613554B2Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 28, 2023·1 cites·17 claims
- 0578US9243010B2Methods for the preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 26, 2016·1 cites·4 claims
- 0677US11479581B2Non-chromatographic purification of macrocyclic peptides by a resin catch and releaseBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 25, 2022·2 cites·7 claims
- 0775US9273067B2Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replicationBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Mar 1, 2016·2 cites·17 claims
- 0874US12077558B2Phosphorus (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophosphorus (V) compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Sep 3, 2024·0 cites·20 claims
- 0973US12018097B2Non-chromatographic purification of macrocyclic peptides by a resin catch and releaseBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Jun 25, 2024·0 cites·2 claims
- 1070US9394322B2Methods for the preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 19, 2016·0 cites·3 claims
- 1169US9403821B2Methods for the preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 2, 2016·0 cites·4 claims
- 1269US9376458B2Methods for the preparation of HIV attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jun 28, 2016·0 cites·2 claims
- 1365US2024166675A1Novel phosphorous (v)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (v) compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1462US2016152644A1Methods for the preparation of hiv attachment inhibitor piperazine prodrug compoundBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 1562US2022177482A1Process for the preparation of n-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamideBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1650US12492217B2Reagents and their use for modular enantiodivergent synthesis of C—P bondsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Dec 9, 2025·0 cites·19 claims
- 1749US11254679B2Process for the preparation of N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrroldin-1-yl)cyclohexyl)acetamideBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 22, 2022·0 cites·1 claims
- 1848US2023416252A1Process toward the manufacture of (6r,10s)-10-{4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)-pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6h)-oneBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1944US10106560B2Process and intermediates for making tubulysin analogsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 23, 2018·0 cites·16 claims
- 2044US2015126752A1Process for the preparation of 2-c-methyl-d-ribonic-gamma-lactoneBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 2143US9518058B2Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamideBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Dec 13, 2016·0 cites·9 claims
- 2242US2016130260A1Tert-butyl sulphoxide method for producing festinavirBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2340US2015183818A1Process for preparing diastereomerically enriched phosphoramidate derivatives of nucleoside compounds for treatment of viral infectionsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 2436US2021395200A1Synthetic processes for the production of 1-((3s,4r)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl)-3-phenylureaBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2532US10221208B2Methods of producing an HIV maturation inhibitorVIIV HEALTHCARE UK NO 4 LTD·Filed 2016·Granted Mar 5, 2019·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Martin D. Eastgate files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →